{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:49:14Z","timestamp":1790254154533,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T00:00:00Z","timestamp":1523577600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sunlin & Priscilla Chou Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4325-6","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T09:19:15Z","timestamp":1523611155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Population-level distribution and putative immunogenicity of cancer neoepitopes"],"prefix":"10.1186","volume":"18","author":[{"given":"Mary A.","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Paralkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihir P.","family":"Paralkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Struck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Ellrott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Margolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Nellore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reid F.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,13]]},"reference":[{"key":"4325_CR1","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1200\/JCO.2011.40.2271","volume":"30","author":"B Weide","year":"2012","unstructured":"Weide B, Zelba H, Derhovanessian E, Pflugfelder A, Eigentler TK, Di Giacorno AM, et al. Functional T cells targeting NY-ESO-1 or Melan-a are predictive for survival of patients with distant melanoma metastasis. J Clin Oncol. 2012;30:1835\u201341.","journal-title":"J Clin Oncol"},{"issue":"6184","key":"4325_CR2","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1126\/science.1251102","volume":"344","author":"E Tran","year":"2014","unstructured":"Tran E, Turcotte S, Gros A, Robbins PF, Lu Y, Dudley ME, et al. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial Cancer. Science. 2014;344(6184):641\u20135.","journal-title":"Science"},{"issue":"5","key":"4325_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1101\/gr.165985.113","volume":"24","author":"SD Brown","year":"2014","unstructured":"Brown SD, Warren RL, Gibb EA, Martin SD, Spinelli JJ, Nelson BH, et al. Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival. Genome Res. 2014;24(5):743\u201350.","journal-title":"Genome Res"},{"issue":"6230","key":"4325_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ, et al. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015;348(6230):124\u20138.","journal-title":"Science"},{"issue":"6280","key":"4325_CR5","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.aaf1490","volume":"351","author":"N McGranahan","year":"2016","unstructured":"McGranahan N, Furness AJS, Rosenthal R, Ramskov S, Lyngaa R, Saini SK, et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science. 2016;351(6280):1463\u20139.","journal-title":"Science"},{"key":"4325_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrclinonc.2013.208","volume":"11","author":"CG Drake","year":"2014","unstructured":"Drake CG, Lipson EJ, Brahmer JR. Breathing new life into immunotherapy: a review of melanoma, lung and kidney cancer. Nat Rev Clin Oncol. 2014;11:24\u201337.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7385","key":"4325_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nature10803","volume":"482","author":"M DuPage","year":"2012","unstructured":"DuPage M, Mazumdar C, Schmidt LM, Cheung AF, Jacks T. Expression of tumor-specific antigens underlies cancer immunoediting. Nature. 2012;482(7385):405\u20139.","journal-title":"Nature"},{"issue":"23","key":"4325_CR8","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","volume":"371","author":"A Snyder","year":"2014","unstructured":"Snyder A, Makarov V, Merghoub T, Yuan J, Zaretsky JM, Desrichard A, et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med. 2014;371(23):2189\u201399.","journal-title":"N Engl J Med"},{"issue":"6257","key":"4325_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.aad0095","volume":"350","author":"EM Van Allen","year":"2015","unstructured":"Van Allen EM, Miao D, Schilling B, Shukla SA, Blank C, Zimmer L, et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science. 2015;350(6257):207\u201311.","journal-title":"Science"},{"issue":"7662","key":"4325_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature22991","volume":"547","author":"PA Ott","year":"2017","unstructured":"Ott PA, Hu Z, Keskin DB, Shukla SA, Sun J, Bozym DJ, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547(7662):217\u201321.","journal-title":"Nature"},{"issue":"7662","key":"4325_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature23003","volume":"547","author":"U Sahin","year":"2017","unstructured":"Sahin U, Derhovanessian E, Miller M, Kloke B, Simon P, Lower M, et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature. 2017;547(7662):222\u20136.","journal-title":"Nature"},{"key":"4325_CR12","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/nrg1489","volume":"5","author":"R Horton","year":"2004","unstructured":"Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, et al. Gene map of the extended human MHC. Nat Rev Genet. 2004;5:889\u201399.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"4325_CR13","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/429393","volume":"76","author":"MM Miretti","year":"2005","unstructured":"Miretti MM, Walsh EC, Ke X, Delgado M, Griffiths M, Hunt S, et al. A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet. 2005;76(4):634\u201346.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"4325_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri3084","volume":"11","author":"J Neefjes","year":"2011","unstructured":"Neefjes J, Jongsma MLM, Paul P, Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol. 2011;11(12):823\u201336.","journal-title":"Nat Rev Immunol"},{"key":"4325_CR15","doi-asserted-by":"publisher","first-page":"jem-20141308","DOI":"10.1084\/jem.20141308","volume":"211","author":"F Duan","year":"2014","unstructured":"Duan F, Duitama J, Al Seesi S, Ayres CM, Corcelli SA, Pawashe AP, et al. Genomic and bioinformatics profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity. J Exp Med. 2014;211:jem-20141308.","journal-title":"J Exp Med"},{"issue":"13","key":"4325_CR16","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1093\/bioinformatics\/btv116","volume":"31","author":"B Schubert","year":"2015","unstructured":"Schubert B, Brachvogel HP, Jurges C, Kohlbacher O. EpiToolKit \u2013 a web-based workbench for vaccine design. Bioinformatics. 2015;31(13):2211\u20133.","journal-title":"Bioinformatics"},{"issue":"1","key":"4325_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13073-016-0264-5","volume":"8","author":"J Hundal","year":"2016","unstructured":"Hundal J, Carreno BM, Petti AA, Linette GP, Griffith OL, Mardis ER, et al. pVAC-Seq: a genome-guided in silico approach to identifying tumor neoantigens. Genome Med. 2016;8(1):11.","journal-title":"Genome Med"},{"issue":"4","key":"4325_CR18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/bioinformatics\/btw674","volume":"33","author":"J Zhang","year":"2016","unstructured":"Zhang J, Mardis ER, Maher CA. INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery. Bioinformatics. 2016;33(4):555\u20137.","journal-title":"Bioinformatics"},{"issue":"4","key":"4325_CR19","doi-asserted-by":"publisher","first-page":"170050","DOI":"10.1098\/rsos.170050","volume":"4","author":"Z Zhou","year":"2017","unstructured":"Zhou Z, Lyu X, Wu J, Yang X, Wu S, Zhou J, et al. TSNAD: an integrated software for cancer somatic mutation and tumor-specific neoantigen detection. R Soc Open Sci. 2017;4(4):170050.","journal-title":"R Soc Open Sci"},{"key":"4325_CR20","doi-asserted-by":"publisher","unstructured":"Bjerregaard A, Nielsen M, Hadrup SR, Szallasi Z, Eklund AC. MuPeXI: prediction of neoepitopes from tumor sequencing data. Cancer Immunol Immunother. 2017; https:\/\/doi.org\/10.1007\/s00262-017-2001-3 .","DOI":"10.1007\/s00262-017-2001-3"},{"key":"4325_CR21","doi-asserted-by":"publisher","unstructured":"Bais P, Namburi S, Gatti DM, Zhang X, Chuang JH. CloudNeo: a cloud pipeline for identifying patient-specific tumor neoantigens. Bioinformatics. 2017; https:\/\/doi.org\/10.1093\/bioinformatics\/btx375 .","DOI":"10.1093\/bioinformatics\/btx375"},{"key":"4325_CR22","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.4049\/jimmunol.153.12.5586","volume":"153","author":"A Sette","year":"1994","unstructured":"Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol. 1994;153:5586\u201392.","journal-title":"J Immunol"},{"issue":"4","key":"4325_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/0092-8674(93)90490-H","volume":"75","author":"DR Madden","year":"1993","unstructured":"Madden DR, Garboczi DN, Wiley DC. The antigenic identify of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell. 1993;75(4):693\u2013708.","journal-title":"Cell"},{"issue":"47","key":"4325_CR24","doi-asserted-by":"publisher","first-page":"17858","DOI":"10.1073\/pnas.0608683103","volume":"103","author":"T Pradeu","year":"2006","unstructured":"Pradeu T, Carosella ED. On the definition of a criterion of immunogenicity. Proc Natl Acad Sci U S A. 2006;103(47):17858\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7528","key":"4325_CR25","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nature14001","volume":"515","author":"M Yadav","year":"2014","unstructured":"Yadav M, Jhunjhunwala S, Phung QT, Lupardus P, Tanguay J, Bumbaca S, et al. Predicting immunogenic tumor mutations by combining mass spectrometry and exome sequencing. Nature. 2014;515(7528):572\u20136.","journal-title":"Nature"},{"key":"4325_CR26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature24473","volume":"551","author":"M Luksza","year":"2017","unstructured":"Luksza M, Riaz N, Makarov V, Balachandron VP, Hellmann MD, Solovyov A, et al. A neoantigen fitness model predicts tumor response to checkpoint blockade immunotherapy. Nature. 2017;551:517\u201320.","journal-title":"Nature"},{"issue":"6161","key":"4325_CR27","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","volume":"3","author":"N Iida","year":"2013","unstructured":"Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, et al. Commensal Bacteria control Cancer response to therapy by modulating the tumor microenvironment. Science. 2013;3(6161):967\u201370.","journal-title":"Science"},{"issue":"6264","key":"4325_CR28","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-LI efficacy. Science. 2015;350(6264):1084\u20139.","journal-title":"Science"},{"issue":"6264","key":"4325_CR29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M Vetizou","year":"2015","unstructured":"Vetizou M, Pitt JM, Daillere R, Lepage P, Waldschmitt N, Flament C, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350(6264):1079\u201384.","journal-title":"Science"},{"key":"4325_CR30","doi-asserted-by":"publisher","first-page":"5696","DOI":"10.4049\/jimmunol.169.10.5696","volume":"169","author":"V Rubio-Godoy","year":"2002","unstructured":"Rubio-Godoy V, Dutoit V, Zhao Y, Simon R, Guillaume P, Houghen R, et al. Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL. J Immunol. 2002;169:5696\u2013707.","journal-title":"J Immunol"},{"issue":"9","key":"4325_CR31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","volume":"92","author":"ML Gillison","year":"2000","unstructured":"Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709\u201320.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"4325_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12\u20139.","journal-title":"J Pathol"},{"issue":"5866","key":"4325_CR33","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1126\/science.1152586","volume":"319","author":"H Feng","year":"2008","unstructured":"Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096\u2013100.","journal-title":"Science"},{"issue":"7","key":"4325_CR34","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1158\/1078-0432.CCR-13-2697","volume":"20","author":"R Lyngaa","year":"2014","unstructured":"Lyngaa R, Pedersen NW, Schrama D, Thrue CA, Ibrani D, Met O, et al. T-cell responses to oncogenic Merkel cell polyomavirus proteins distinguish Merkel cell carcinoma patients from health donors. Clin Cancer Res. 2014;20(7):1668\u201378.","journal-title":"Clin Cancer Res"},{"key":"4325_CR35","doi-asserted-by":"publisher","first-page":"10915","DOI":"10.1073\/pnas.89.22.10915","volume":"89","author":"S Henikoff","year":"1992","unstructured":"Henikoff S, Henikoff JG. Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A. 1992;89:10915\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4325_CR36","first-page":"213","volume":"31","author":"K Cibulkis","year":"2013","unstructured":"Cibulkis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nature. Biotechnol. 2013;31:213\u20139.","journal-title":"Biotechnol"},{"key":"4325_CR37","unstructured":"Spangler R: gdc-scan. https:\/\/github.com\/ohsu-comp-bio\/gdc-scan (2017). Accessed 1 May 2016."},{"key":"4325_CR38","unstructured":"Memorial Sloan Kettering: vcf2maf. https:\/\/github.com\/mskcc\/vcf2maf (2017). Accessed 2 May 2017."},{"key":"4325_CR39","unstructured":"Broad Institute: Resource Bundle. ftp:\/\/gsapubftp-anonymous@ftp.broadinstitute.org\/bundle\/hg38\/Homo_sapiens_assembly38.fasta.gz (2016). Accessed 17 Mar 2017."},{"issue":"1","key":"4325_CR40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, et al. The Ensembl variant effect predictor. Genome Biol. 2016;17(1):122.","journal-title":"Genome Biol"},{"key":"4325_CR41","unstructured":"Hundal J, Kiwala S, Graubert A, Walker J, Miller C, Griffith M, et al.: Usage. http:\/\/pvac-seq.readthedocs.io\/en\/v4.0.8\/run.html (2016). Accessed 2 May 2017."},{"key":"4325_CR42","unstructured":"Ensembl: VEP_plugins. https:\/\/github.com\/Ensembl\/VEP_plugins (2017). Accessed 15 Mar 2017."},{"issue":"1","key":"4325_CR43","first-page":"32","volume":"6","author":"F Cunningham","year":"2015","unstructured":"Cunningham F, Moore B, Ruiz-Schultz M, Ritchie GR, Eilbeck K. Improving the sequence ontology terminology for genomic variant annotation. J Biomed Sci. 2015;6(1):32.","journal-title":"J Biomed Sci"},{"key":"4325_CR44","doi-asserted-by":"publisher","first-page":"D913","DOI":"10.1093\/nar\/gkq1128","volume":"39","author":"FF Gonzalez-Galarza","year":"2011","unstructured":"Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res. 2011;39:D913\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"4325_CR45","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/nbt.3344","volume":"33","author":"SA Shukla","year":"2015","unstructured":"Shukla SA, Rooney MS, Rajasagi M, Tiao G, Dixon PM, Lawrence MS, et al. Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes. Nat Biotechnol. 2015;33(11):1152\u20138.","journal-title":"Nat Biotechnol"},{"issue":"8","key":"4325_CR46","doi-asserted-by":"publisher","first-page":"e796","DOI":"10.1371\/journal.pone.0000796","volume":"2","author":"M Nielsen","year":"2007","unstructured":"Nielsen M, Lundegaard C, Blicher T, Lamberth K, Harndahl M, Justesen S, et al. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and \u2013B locus protein of known sequence. PLoS One. 2007;2(8):e796.","journal-title":"PLoS One"},{"key":"4325_CR47","unstructured":"Python Software Foundation: random \u2013 Generate pseudo-random numbers. https:\/\/docs.python.org\/2\/library\/random.html (2017). Accessed 7 Aug 2017."},{"key":"4325_CR48","unstructured":"Wood, M: neoepitope_novelty. https:\/\/github.com\/ohsu-comp-bio\/neoepitope_novelty (2017). Accessed 23 Aug 2017."},{"issue":"1","key":"4325_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo W, Zaretsky JM, Sun L, Song C, Moreno BH, Hu-Lieskovan S, et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell. 2016;165(1):35\u201344.","journal-title":"Cell"},{"key":"4325_CR50","doi-asserted-by":"publisher","unstructured":"Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines. PMID: 29596782. https:\/\/doi.org\/10.1016\/j.cels.2018.03.002 .","DOI":"10.1016\/j.cels.2018.03.002"},{"issue":"14","key":"4325_CR51","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics"},{"key":"4325_CR52","unstructured":"Tischler, G: biobambam2. https:\/\/github.com\/gt1\/biobambam2 (2017)."},{"issue":"9","key":"4325_CR53","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297\u20133030.","journal-title":"Genome Res"},{"issue":"3","key":"4325_CR54","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22(3):568\u201376.","journal-title":"Genome Res"},{"key":"4325_CR55","unstructured":"GENCODE: Release 19. ftp:\/\/ftp.sanger.ac.uk\/pub\/gencode\/Gencode_human\/release_19\/gencode.v19.annotation.gtf.gz (2017). Accessed 19 Jun 2017."},{"issue":"23","key":"4325_CR56","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1093\/bioinformatics\/btu548","volume":"30","author":"A Szolek","year":"2014","unstructured":"Szolek A, Schubert B, Mohr C, Sturm M, Feldhahn M, Kohlbacher O. Optitype: precision HLA typing from next-generation sequencing data. Bioinformatics. 2014;30(23):3310\u20136.","journal-title":"Bioinformatics"},{"key":"4325_CR57","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1146\/annurev.immunol.23.021704.115658","volume":"24","author":"M Rudolph","year":"2006","unstructured":"Rudolph M, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and Coreceptors. Annu Rev Immunol. 2006;24:419\u201366.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"4325_CR58","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/1471-2105-10-421","volume":"10","author":"C Camacho","year":"2009","unstructured":"Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, et al. BLAST+: architecture and applications. BMC Bioinform. 2009;10(1):421.","journal-title":"BMC Bioinform"},{"key":"4325_CR59","unstructured":"Ensembl: Gene Annotation. ftp:\/\/ftp.ensembl.org\/pub\/release-88\/fasta\/homo_sapiens\/pep\/Homo_sapiens.GRCh38.pep.all.fa.gz (2017). Accessed 12 Apr 2017."},{"key":"4325_CR60","unstructured":"National Center for Biotechnology Information: RefSeq Release \u2013 Bacteria. ftp:\/\/ftp.ncbi.nlm.nih.gov\/refseq\/release\/bacteria\/ (2017). Accessed 13 Jul 2017."},{"key":"4325_CR61","unstructured":"National Center for Biotechnology Information: RefSeq Release \u2013 Viral. ftp:\/\/ftp.ncbi.nlm.nih.gov\/refseq\/release\/viral\/ (2017). Accessed 13 Jul 2017."},{"issue":"6236","key":"4325_CR62","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1126\/science.aaa3828","volume":"348","author":"BM Carreno","year":"2015","unstructured":"Carreno BM, Magrini V, Becker-Hapak M, Kaabinejadian S, Hundal J, Petti AA, et al. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science. 2015;348(6236):803\u20138.","journal-title":"Science"},{"issue":"4","key":"4325_CR63","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nm.4051","volume":"22","author":"A Gros","year":"2016","unstructured":"Gros A, Parkhurst MR, Tran E, Pasetto A, Robbins PF, Ilyas S, et al. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients. Nat Med. 2016;22(4):433\u20138.","journal-title":"Nat Med"},{"issue":"6349","key":"4325_CR64","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, et al. Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409\u201313.","journal-title":"Science"},{"key":"4325_CR65","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: machine learning in Python. J Mach Learn Res. 2011;12:2825\u201330.","journal-title":"J Mach Learn Res"},{"key":"4325_CR66","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"key":"4325_CR67","doi-asserted-by":"publisher","unstructured":"Turajlic S, Litchfield K, Xu H, Rosenthal R, McGranahan N, Reading JL, et al. Insertion-and-deletion-derived tumor-specific neoantigens and the immunogenic phenotype: a pan-cancer-analysis. Lancet Oncol. 2017; https:\/\/doi.org\/10.1016\/S1470-2045(17)30516-8 .","DOI":"10.1016\/S1470-2045(17)30516-8"},{"issue":"3","key":"4325_CR68","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1073\/pnas.0408864102","volume":"103","author":"S Kang","year":"2005","unstructured":"Kang S, Bader AG, Vogt PK. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. PNAS. 2005;103(3):802\u20137.","journal-title":"PNAS"},{"key":"4325_CR69","first-page":"57","volume":"7","author":"S Surget","year":"2014","unstructured":"Surget S, Khoury MP, Bourdon J. Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. Onco Targets Ther. 2014;7:57\u201368.","journal-title":"Onco Targets Ther"},{"issue":"4","key":"4325_CR70","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/172460089801300402","volume":"13","author":"RC Bast Jr","year":"1998","unstructured":"Bast RC Jr, Xu FJ, Yu YH, Barnhill S, Zhang Z, Mills GB. CA 125: the past and the future. Int J Biol Markers. 1998;13(4):179\u201387.","journal-title":"Int J Biol Markers"},{"issue":"4","key":"4325_CR71","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/archinte.161.4.525","volume":"161","author":"E Mylonakis","year":"2001","unstructured":"Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile-associated diarrhea. JAMA Intern Med. 2001;161(4):525\u201333.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"4325_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0962-8479(95)90591-X","volume":"76","author":"LM O\u2019Reilly","year":"1995","unstructured":"O\u2019Reilly LM, Daborn CJ. The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tuber Lung Dis. 1995;76(1):1\u201346.","journal-title":"Tuber Lung Dis"},{"issue":"8","key":"4325_CR73","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3201\/eid0805.020002","volume":"8","author":"JR Glynn","year":"2002","unstructured":"Glynn JR, Whitely J, Bifani PJ, Kremer K, van Soolingen D. Worldwide occurrence of Beijing\/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis. 2002;8(8):843\u20139.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"4325_CR74","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1016\/j.ijid.2010.11.003","volume":"15","author":"MA Horseman","year":"2011","unstructured":"Horseman MA, Surani S. A comprehensive review of Vibrio vulnificus: an important cause of severe sepsis and skin and soft tissue infection. Int J Infect Dis. 2011;15(3):e157\u201366.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"4325_CR75","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/QCO.0b013e32832a8a5d","volume":"22","author":"CD Packey","year":"2009","unstructured":"Packey CD, Sartor RB. Commensal Bacteria, traditional and Opportunisitic pathogens, Disybiosis, and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis. 2009;22(3):292\u2013301.","journal-title":"Curr Opin Infect Dis"},{"key":"4325_CR76","unstructured":"National Center for Biotechnology Information: SRA. https:\/\/www.ncbi.nlm.nih.gov\/sra (2017)."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4325-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4325-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4325-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T23:17:18Z","timestamp":1693610238000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4325-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,13]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4325"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4325-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/192716","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,13]]},"assertion":[{"value":"21 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"414"}}